EFFICACY AND SAFETY STUDY OF THE ANTIHISTAMINE V0114CP 2.5MG IN THE TREATMENT OF SEASONAL ALLERGIC RHINITIS. RANDOMISED, DOUBLE-BLIND, THREE ARM PARALLEL GROUP STUDY INCLUDING PLACEBO AND ACTIVE CONTROL ARM (DESLORATADINE 5 MG)
EFFICACY AND SAFETY STUDY OF THE ANTIHISTAMINE V0114CP 2.5MG IN THE TREATMENT OF SEASONAL ALLERGIC RHINITIS. RANDOMISED, DOUBLE-BLIND, THREE ARM PARALLEL GROUP STUDY INCLUDING PLACEBO AND ACTIVE CONTROL ARM (DESLORATADINE 5 MG)
EFFICACY AND SAFETY STUDY OF THE ANTIHISTAMINE V0114CP 2.5MG IN THE TREATMENT OF SEASONAL ALLERGIC RHINITIS. RANDOMISED, DOUBLE-BLIND, THREE ARM PARALLEL GROUP STUDY INCLUDING PLACEBO AND ACTIVE CONTROL ARM (DESLORATADINE 5 MG)
Statut
Status :
Terminé
Type d'étude
Phase III
Age Min.
18
Ans
Age Max.
-
Genre
Tous
Aire thérapeutique :
Allergies
Maladie :
Rhinite allergique
Traitement :
L-mequitazine (Xyzall®)
Phase :
Phase III
Date de début de l'étude :
22 Mai 2008
End date :
27 Août 2008
Identifiant de l'essai :
V00114 CP 304 2A
Identifiant EudraCT/CTIS :
2008-001860-362008-000133-22
Envoyer par email